NCT02954939View on ClinicalTrials.gov

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Lupus Nephritis
Interventions
DRUG

MMF-MMF

Class III/IV+/-V lupus nephritis patients to receive PRED+MMF

DRUG

CTX-AZA

Class III/IV+/-V lupus nephritis patients to receive PRED+CTX followed by AZA

Trial Locations (1)

Unknown

RECRUITING

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER